Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

33 results
  1. ... syndrome, however, the result was not statistically significant. Additional studies have demonstrated similar survival outcomes ... that develop via the MSI pathway have more ...
  2. ... often with adjuvant intravesical therapy to destroy residual tumor cells using chemotherapeutic agents (e.g., ... Fatigue Syndrome Pacific Northwest ...
  3. ... abdominoperineal resection. Alternatively, patients may be treated with ... for patients with early-stage tumors smaller than 1 cm. It is also unclear ...
  4. ... the hypothesis that anaplasia evolves as a late event from a subpopulation of Wilms ... with responsiveness to therapy rather than to tumor aggressiveness. It is most ...
  5. ... efficacy of Iscador as an adjuvant long-term treatment after surgery for ... the use of immunotherapy was more frequent in the control group. Only ...
  6. ... New drug regimens. Surgical resection of the primary tumor. New radiation therapy schedules and techniques (e.g., timing, three-dimensional ... review showed that 43% of patients treated with additional chemotherapy at the ... tumor have achieved successful palliation with endobronchial laser therapy ( ...
  7. ... reporting a significant benefit, with patients receiving the additional maintenance therapy having an increased event free ( Le Gouill et al. , 2014 ) and progression ...
  8. ... a side effect of a growing tumor or treatment of the tumor. For patients with cancer, additional causative factors are the following:[ 1 ] The tumor ... Memon et al. as reference 11 . Diarrhea Added immunotherapy as ... Unique scenarios as a new subsection. This summary is written and maintained by ...
  9. ... el cáncer</language-mapped-topic><mesh-heading ><descriptor >Neoplasms</descriptor><qualifier >therapy</qualifier></mesh-heading><mesh-heading ><descriptor >Immunotherapy</descriptor></mesh-heading><other-language >Spanish</other-language>< ...
  10. ... with morbidity of the intervention. The role of new targeted and immunotherapy in unresectable in transit metastases compared with currently available regional therapies is not well defined compared with current options ...
first · previous · 1 · 2 · 3 · 4 · next · last